Global Remicade Biosimilar Market Report By Disease Indication (Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis And Plaque Psoriasis) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210446
February 2020
Report Formats:

As per this study the Global Remicade Biosimilar Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Biosimilar refers to biopharmaceutical drug, which resembles the existing licensed therapeutic drug in terms of quality, efficiency and safety. Remicade is the commercially available brand name of infliximab. Infliximab is the chimeric monoclonal antibody biologic drug used to treat autoimmune diseases such as treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis (a type of spinal arthritis), psoriatic arthritis, and the red, scaly skin patches of plaque psoriasis. Biosimilar for remicade are inflectra, renflexis, remsima and flixabi.
 
Market Dynamics
 
Rising market competitiveness resulting into a decline in the prices of biosimilar products is driving the market growth. Use of biosimilar products to improve patients’ access to medicine by offering financial relief is further fueling the market growth. Also, growing healthcare expenditure followed by a rise in the prevalence of autoimmune medical conditions is again boosting the market demand. However, serious side effects followed by stringent regulatory guidelines for the development of these biosimilar drugs may hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of remicade biosimilar.
 
Market Segmentation
 
The broad remicade biosimilar market has been sub-grouped into disease indication. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Disease Indication

  • Ulcerative Colitis
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Crohn’s Disease
  • Psoriatic Arthritis
  • Plaque Psoriasis
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for remicade biosimilar in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Remicade Biosimilar Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the remicade biosimilar market include Alvogen, Celltrion, Janssen Biotech, Inc., Merck and Company, Inc., Napp Pharmaceuticals, Nippon Kayaku and Pfizer, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Remicade Biosimilar  Market
       2.2. Global Remicade Biosimilar  Market Snapshot
 
3 . REMICADE BIOSIMILAR  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Remicade Biosimilar  Market
       3.3. Market Restraints of Remicade Biosimilar  Market
       3.4. Opportunities of Remicade Biosimilar  Market
       3.5. Trends of Remicade Biosimilar  Market
       3.6. Porter’s Five Force Analysis of Remicade Biosimilar  Market
       3.7. Remicade Biosimilar  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Disease Indication
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Remicade Biosimilar  Value Chain Analysis
       4.2. Remicade Biosimilar  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Remicade Biosimilar  Raw Material Manufactures List
           4.2.3. Price Trend of Remicade Biosimilar  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL REMICADE BIOSIMILAR  MARKET ANALYSIS BY DISEASE INDICATION
       5.1 Overview by Disease Indication
       5.2 Global Remicade Biosimilar  Market Analysis by Disease Indication
       5.3 Market Analysis of Ulcerative Colitis by Regions
       5.4 Market Analysis of Rheumatoid Arthritis by Regions
       5.5 Market Analysis of Ankylosing Spondylitis by Regions
       5.6 Market Analysis of Crohn’s Disease by Regions
       5.7 Market Analysis of Psoriatic Arthritis by Regions
       5.8 Market Analysis of Plaque Psoriasis by Regions
 
6 . GLOBAL REMICADE BIOSIMILAR  MARKET ANALYSIS BY GEOGRAPHY
       6.1. Regional Outlook
       6.2. Introduction
       6.3. North America
           6.3.1. Overview
           6.3.2. North America Remicade Biosimilar  Market Estimate by Market Segment
           6.3.3. North America Remicade Biosimilar  Market Estimate by Country
           6.3.4. United State
           6.3.5. Rest of North America
       6.4. Europe
           6.4.1. Overview
           6.4.2. Europe Remicade Biosimilar  Market Estimate by Market Segment
           6.4.3. Europe Remicade Biosimilar  Market Estimate by Country
           6.4.4. United Kingdom
           6.4.5. France
           6.4.6. Germany
           6.4.6 Rest of Europe
       6.5. Asia Pacific
           6.5.1. Overview
           6.5.2. Asia Pacific Remicade Biosimilar  Market Estimate by Market Segment
           6.5.3. Asia Pacific Remicade Biosimilar  Market Estimate by Country
           6.5.4. China
           6.5.5. Japan
           6.5.6. India
           6.5.6. Rest of Asia Pacific
       6.6. Latin America
           6.6.1. Overview
           6.6.2. Latin America Remicade Biosimilar  Market Estimate by Market Segment
           6.6.3. Latin America Remicade Biosimilar  Market Estimate by Country
           6.6.4. Brazil
           6.6.5. Rest of Latin America
       6.7. Middle East & Africa
           6.7.1. Overview
           6.7.2. Middle East & Africa Remicade Biosimilar  Market Estimate by Market Segment
           6.7.3. Middle East & Africa Remicade Biosimilar  Market Estimate by Country
           6.7.4. Middle East
           6.7.5. Africa
 
7 . COMPETITIVE LANDSCAPE OF THE REMICADE BIOSIMILAR  COMPANIES
       7.1. Remicade Biosimilar  Market Competition
       7.2. Partnership/Collaboration/Agreement
       7.3. Merger And Acquisitions
       7.4. New Product Launch
       7.5. Other Developments
 
8 . COMPANY PROFILES OF REMICADE BIOSIMILAR  INDUSTRY
       8.1. Company Share Analysis
       8.2. Market Concentration Rate
       8.3. Alvogen
           8.3.1. Company Overview
           8.3.2. Financials
           8.3.3. Products
           8.3.4. Recent Developments
       8.4. Celltrion
           8.4.1. Company Overview
           8.4.2. Financials
           8.4.3. Products
           8.4.4. Recent Developments
       8.5. Janssen Biotech, Inc.
           8.5.1. Company Overview
           8.5.2. Financials
           8.5.3. Products
           8.5.4. Recent Developments
       8.6. Merck and Company, Inc.
           8.6.1. Company Overview
           8.6.2. Financials
           8.6.3. Products
           8.6.4. Recent Developments
       8.7. Napp Pharmaceuticals
           8.7.1. Company Overview
           8.7.2. Financials
           8.7.3. Products
           8.7.4. Recent Developments
       8.8. Nippon Kayaku
           8.8.1. Company Overview
           8.8.2. Financials
           8.8.3. Products
           8.8.4. Recent Developments
       8.9. Pfizer, Inc.
           8.9.1. Company Overview
           8.9.2. Financials
           8.9.3. Products
           8.9.4. Recent Developments
 
9.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       9.1. Impact Analysis of Covid-19 Outbreak on the Market
           9.1.1. Direct Impact on Production
           9.1.2. Supply Chain and Market Disruption
           9.1.3. Financial Impact on Firms and Financial Markets
       9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       9.3. Pre V/S Post COVID-19 Market
       9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       9.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Ulcerative Colitis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Rheumatoid Arthritis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Ankylosing Spondylitis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Crohn’s Disease by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Psoriatic Arthritis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Plaque Psoriasis by Geography (USD MN)
  • Global Remicade Biosimilar  Market by Geography (USD MN)
  • North America Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • North America Remicade Biosimilar  Market Estimate by Country (USD MN)
  • United State Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Rest of North America Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Europe Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • United Kingdom Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • France Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Germany Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Rest of Europe Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Asia Pacific Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Asia Pacific Remicade Biosimilar  Market Estimate by Country (USD MN)
  • China Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Japan Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • India Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Rest of Asia Pacific Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Latin America Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Latin America Remicade Biosimilar  Market Estimate by Country (USD MN)
  • Brazil Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Rest of Latin America Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Middle East & Africa Remicade Biosimilar  Market Estimate by Disease Indication (USD MN)
  • Middle East & Africa Remicade Biosimilar  Market Estimate by Country (USD MN)
  • Middle East Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Africa Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Remicade Biosimilar  Report
  • Market Research Process
  • Market Research Methodology
  • Global Remicade Biosimilar  Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Remicade Biosimilar  Market Analysis by Disease Indication (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Ulcerative Colitis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Rheumatoid Arthritis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Ankylosing Spondylitis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Crohn’s Disease by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Psoriatic Arthritis by Geography (USD MN)
  • Global Remicade Biosimilar  Market Analysis in Plaque Psoriasis by Geography (USD MN)
  • Latin America Remicade Biosimilar  Market by Revenue
  • Middle East & Africa Remicade Biosimilar  Market by Revenue
  • Recent Development in Remicade Biosimilar  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials